Sage discontinues Zulresso, drops pair of pipeline prospects as it creeps toward 2026 cash cliff
Fierce Pharma
OCTOBER 30, 2024
Ever since the FDA rejected zuranolone in major depressive disorder last year, brai | In the wake of a recent round of layoffs, the company this week revealed that it’s discontinuing a commercial medicine and giving up hopes for a pair of pipeline prospects.
Let's personalize your content